Specify Company / Ticker to Get the Summary
Abbott India Limited
ABBOTINDIAAbbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited. Address: Godrej BKC, Plot C-68, Mumbai, India, 400051
Analytics
WallStreet Target Price
2 439 743.98 INRP/E ratio
48.78Dividend Yield
1.38 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ABBOTINDIA
Dividend Analytics ABBOTINDIA
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
531.00 %Consecutive Years
2 years5Y Average Payout Ratio
55.00 %Dividend History ABBOTINDIA
Stock Valuation ABBOTINDIA
Financials ABBOTINDIA
Results | 2019 | Dynamics |